Monsanto Company (NYSE: MON) and TargetGene Biotechnologies LTD, a pioneer in genome-editing technologies, have announced a license agreement to advance ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE